You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Factors predicting the outcome of disease activity assessment in Crohn's disease

Stjernman, Henrik MD1,*; Tysk, Curt PhD2,3; Almer, Sven PhD4; Ström, Magnus PhD4; Hjortswang, Henrik PhD4

Inflammatory Bowel Diseases:
doi: 10.1002/ibd.20975
Original Clinical Articles
Abstract

Background: The Crohn's Disease Activity Index (CDAI) has become the gold standard for assessment of disease activity in CD. This study investigated the relationship between CDAI and the physicians' global assessment of disease activity (PGA) and whether different demographic and disease‐related factors predict the outcome.

Methods: Multiple linear regression analysis was used to investigate the relationship between CDAI and PGA obtained from 405 CD patients. Predictors of the CDAI and the PGA outcome were identified.

Results: The correlation between CDAI and PGA was moderate. In patients with CDAI >150, 72% of the total score were derived from the subjective variables. The regression coefficients were not significant for 3 of the CDAI variables. In regression analysis, C‐reactive protein (CRP), stenosis, smoking, bowel resection, concomitant disease, and gender predicted the CDAI outcome. The PGA outcome was predicted only by CRP, stenosis, and fistula.

Conclusions: The correlation between CDAI and PGA was moderate and the subjective variables had a high impact on CDAI. Factors with no obvious relation to inflammatory activity predicted the outcome of CDAI, but not PGA. In trials of CD therapies, separation of subjective (symptoms, well‐being) from objective (endoscopy, inflammatory markers) variables should be considered in the assessment of disease activity. Inflamm Bowel Dis 2009

Author Information

1 Division of Gastroenterology, Department of Medicine, County Hospital Ryhov, Jönköping, Sweden

2 Division of Gastroenterology, Department of Medicine, Örebro University Hospital, Örebro, Sweden

3 School of Health and Medical Sciences, Örebro University, Örebro, Sweden

4 Division of Gastroenterology and Hepatology, Department of Clinical and Experimental Medicine, Linköping University Hospital, Linköping, Sweden

*Reprints: Division of Gastroenterology, Department of Internal Medicine, County Hospital Ryhov, S‐551 85 Jönköping. Sweden

Email: henrik.stjernman@lj.se

Received 12 March 2009; Accepted 24 March 2009

Published online 2 July 2009 in Wiley Online Library (wileyonlinelibrary.com).

Grant sponsor: Research Council of the South East of Sweden; Grant sponsor: Futurum‐the Academy of Healthcare; Grant sponsor: Jönköping County Council, Sweden\.

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.